P3: REGULATION OF PPARGAMMA IN ADIPOCYTES BY THE UBIQUITIN-PROTEASOME SYSTEM

$205,804P20FY2010RRNIH

Lsu Pennington Biomedical Research Ctr, Baton Rouge LA

Investigators

Linked publications & trials

Paper 35625635 Paper 33396678 Paper 33285301 Paper 30930963 Paper 30226002 Paper 29951570 Paper 29901267 Paper 29777200 Paper 29566074 Paper 29547847 Paper 29504255 Paper 29437573 Paper 29274999 Paper 29151595 Paper 29146412 Paper 29071793 Paper 29031410 Paper 28982014 Paper 28859876 Paper 28811495 Paper 28772276 Paper 28520765 Paper 28473468 Paper 28446632 Paper 28420714 Paper 28386755 Paper 28302572 Paper 28096260 Paper 28061324 Paper 27892502 Paper 27645401 Paper 27396336 Paper 27184848 Paper 27173459 Paper 26974425 Paper 26936965 Paper 26930489 Paper 26847390 Paper 26823127 Paper 26774965 Paper 26554604 Paper 26538189 Paper 26500842 Paper 26248309 Paper 26024297 Paper 26005096 Paper 25903638 Paper 25895849 Paper 25564477 Paper 25446648 Paper 25349056 Paper 25305050 Paper 25173628 Paper 24982244 Paper 24848065 Paper 24795999 Paper 24639082 Paper 24632837 Paper 24569592 Paper 24562631 Paper 24491834 Paper 24373243 Paper 24265370 Paper 24199156 Paper 24189525 Paper 24154509 Paper 24105415 Paper 24020699 Paper 23818429 Paper 23813805 Paper 23748190 Paper 23482448 Paper 23458626 Paper 23437325 Paper 23391242 Paper 23364451 Paper 23313575 Paper 23233541 Paper 23150693 Paper 23116605 Paper 23100231 Paper 23093952 Paper 23053893 Paper 22915197 Paper 22912823 Paper 22832107 Paper 22787396 Paper 22751692 Paper 22711354 Paper 22580130 Paper 22516953 Paper 22474028 Paper 22411258 Paper 22407349 Paper 22355175 Paper 22338096 Paper 22315447 Paper 22314623 Paper 22310476 Paper 22294748

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A. Specific Aims In March 2009, the external reviewers indicated that our project "has the potential to reveal new mechanistic insights" into the regulation of PPARgamma and that our initial screen of ubiquitin E3 ligases has identified "E3 ligases that appear to influence steady state levels of PPARgamma within cells". The reviewers also advised that "successfully competing for an R01 in this area is likely to require narrowing the focus to one or two enzymes that play functional roles in PPARgamma action". A primary concern continued to be linking PPARgamma ubiquitylation and degradation to PPARgamma transcriptional function or a down-stream metabolic alteration. Recommendations for achieving these goals centered on continuing our experiments with the E3 ligases by focusing on one or two ligases, determining whether the effect of the E3 ligase on PPARgamma protein levels is direct or indirect and considering the effect of the selected E3 ligase on adipogenesis. In addition, the reviewers recommended we focus on ubiquitin proteasome modification of PPARgamma as a regulated posttranslational modification of PPARgamma. In response to the reviewers'suggestions, we pursued the following aims: Specific Aim 1: Complete the secondary screen to identify ubiquitin E3 ligases that regulate PPARgamma protein levels in mature adipocytes. Specific Aim 2: Examine the effect of the selected ligase or ligases on ligand-enhanced ubiquitylation and proteasome-dependent degradation of PPARgamma. Specific Aim 3: Determine the effect of the identified ligase or ligases on adipogenesis.

View original record on NIH RePORTER →